数据链接：
官方服务：
资源简介：
PCSK9 in complex with an inhibitor
应用场景：
创建时间：
2025-04-30
相关数据集
Lipid parameters in different patient populations before and during (12 weeks) of therapy with PCSK9 inhibitors.
Lipid parameters in different patient populations before and during (12 weeks) of therapy with PCSK9 inhibitors.
NIAID Data Ecosystem80
Small Molecule Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors: Hit to Lead Optimization of Systemic Agents
The optimization of a new class of small molecule PCSK9 mRNA translation inhibitors is described. The potency, physicochemical properties, and off-target pharmacology associated with the hit compound
NIAID Data Ecosystem60
Data for: The effect of PCSK9 Inhibition on the Plasma Proteome: A SPIRE SubStudy
Anonymized dataset belonging to publication "The effect of proprotein convertase subtilisin/kexin type 9 inhibition on the plasma proteome: a SPIRE sub-study" by Kraaijenhof et al.
Harvard Dataverse2023-06-15 更新10
PCSK9(deltaCRD) in complex with cyclic peptide 83
PCSK9(deltaCRD) in complex with cyclic peptide 83 Descriptor: GLYCEROL, Peptide 83, Proprotein convertase subtilisin/kexin type 9 Authors: Orth, P. Deposit date: 2020-06-19 Release date: 2020-11-18 La
Protein Data Bank Japan2024-07-10 更新70
Potent Lys Patch-Containing Stapled Peptides Targeting PCSK9
Proprotein convertase subtilisin/kexin type 9 (PCSK9), identified as a regulator of low-density lipoprotein receptor (LDLR), plays a major role in cardiovascular diseases (CVD). Recently, Pep2-8, a sm
NIAID Data Ecosystem50
